Pub. Date : 2018
PMID : 30150888
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The comparison of anthracycline-based and non-anthracycline-based regimens in adjuvant chemotherapy of HER2-positive non-metastatic breast cancers. | Anthracyclines | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
| 2 | The comparison of anthracycline-based and non-anthracycline-based regimens in adjuvant chemotherapy of HER2-positive non-metastatic breast cancers. | Anthracyclines | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
| 3 | Aim of the study: This study aimed to assess the efficacy of anthracycline-based (AB) and non-anthracycline-based (nAB) adjuvant therapies in the human epidermal growth factor receptor 2 (HER2)-positive non-metastatic BC (nMBC) patients. | Anthracyclines | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
| 4 | Aim of the study: This study aimed to assess the efficacy of anthracycline-based (AB) and non-anthracycline-based (nAB) adjuvant therapies in the human epidermal growth factor receptor 2 (HER2)-positive non-metastatic BC (nMBC) patients. | Anthracyclines | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
| 5 | Aim of the study: This study aimed to assess the efficacy of anthracycline-based (AB) and non-anthracycline-based (nAB) adjuvant therapies in the human epidermal growth factor receptor 2 (HER2)-positive non-metastatic BC (nMBC) patients. | Anthracyclines | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
| 6 | Aim of the study: This study aimed to assess the efficacy of anthracycline-based (AB) and non-anthracycline-based (nAB) adjuvant therapies in the human epidermal growth factor receptor 2 (HER2)-positive non-metastatic BC (nMBC) patients. | Anthracyclines | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |